Ondansetron Tablets 4 mg, 8 mg

Hazard statements (CLP)

H302, H351

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

GHS US classification Classification of the substance or mixture GHS-US classification Acute Tox. 4 (Oral) H302 Carc. 2 H351 Full text of H-statements: see section 16 (Carc. 2 through inhalation of dust due to Titanium Dioxide content)

2.2 Label elements

GHS-US labelling

Hazard pictograms

GHS07 GHS08

Signal word

Warning

Hazard statements

H302 - Harmful if swallowed H351 - Suspected of causing cancer

Precautionary statements

P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P264 - Wash hands thoroughly after handling P270 - Do not eat, drink or smoke when using this product P280 - Wear protective gloves P301+P312 - If swallowed: Call a doctor if you feel unwell P308+P313 - If exposed or concerned: Get medical advice/attention P330 - Rinse mouth P405 - Store locked up P501 - Dispose of contents/container to an authorised waste collection point

2.3 Other hazards

No additional information available

Ingredient(s) with unknown acute toxicity

6.9 percent of the mixture consists of ingredient(s) of unknown acute toxicity (Dermal) 6.9 percent of the mixture consists of ingredient(s) of unknown acute toxicity (Inhalation (Dust/Mist))

2.1 Classification of the substance or mixture

GHS-US classification Acute Tox. 4 (Oral) H302 Carc. 2 H351 Full text of H-statements: see section 16 (Carc. 2 through inhalation of dust due to Titanium Dioxide content)